Preclinical Oncology Platforms
We develop innovative preclinical models and services that enable informed decision making and compound evaluation. De-risk drug development and move your therapeutic into the clinic faster.
JAX Preclinical Services offers the most translational and predictive efficacy, pharmacokinetics (PK) and safety testing for therapeutics such as monoclonal antibodies, bispecifics, CAR-T, antibody-drug conjugates, and combination therapies.
By combining genetically defined tumors with innovative humanized mouse models, JAX enables the validation of therapeutic candidates in an array of in vivo platforms that better recapitulate the human condition.
